Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway

被引:22
|
作者
Liu, Xia [1 ]
Peng, Jiamin [2 ]
Zhou, Yayun [2 ]
Xie, Bei [2 ]
Wang, Jianchao [3 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Cent Lab, 318 C haowang Rd, Hangzhou 310005, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou 310005, Zhejiang, Peoples R China
[3] Zhejiang Tongde Hosp Zhejiang Prov, Dept Clin Lab, 234 Gucui Rd, Hangzhou 310012, Zhejiang, Peoples R China
关键词
multiple myeloma; ribonucleotide reductase M2; DNA damage; apoptosis; Wnt/beta-catenin signaling; RIBONUCLEOTIDE REDUCTASE M2; THERAPEUTIC TARGET; RNA INTERFERENCE; CANCER; SUBUNIT; EXPRESSION; CELLS; SUPPRESSION; APOPTOSIS; PROMOTES;
D O I
10.3892/mmr.2019.10465
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ribonucleotide reductase M2 (RRM2) is one of the two subunits that comprise ribonucleotide reductase (RR), the enzyme that catalyzes the conversion of ribonucleotide 5'-diphosphates into 2'-deoxyribonucleotides, which are required for DNA synthesis. RRM2 is a stress response factor important for the development of several tumors. However, its role in multiple myeloma (MM) remains to be fully elucidated. The present study aimed to investigate the role of RRM2 in MM. The expression of RRM2 in patients with MM was analyzed using the Oncomine database. The results demonstrated that RRM2 expression was higher in MM compared with healthy subjects. Reverse transcription-quantitative polymerase chain reaction and western blot results revealed that RRM2 expression was decreased following transfection with a small interfering RNA targeting RRM2 into NCI-H929 cells. RR activity and Cell Counting Kit-8 assays demonstrated that RRM2 silencing reduced RR activity and inhibited cell proliferation. Annexin V-propidium iodide staining indicated that the percentage of apoptotic NCI-H929 cells was increased following RRM2 silencing compared with that in the control group. Increased phosphorylation of H2AX indicated that RRM2 silencing may activate the DNA-damage response pathway in NCI-H929 cells. Western blot analysis revealed that protein levels of the apoptosis-associated factor Bcl-2 were reduced, whereas Bax, cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase 1 were upregulated following RRM2 silencing compared with the control group. In addition, the results demonstrated that RRM2 silencing may inhibit target gene expression in the Wnt/beta-catenin signaling pathway by increasing the phosphorylation of glucose synthase kinase 3 beta. These findings indicated that RRM2 may be involved in the proliferation and apoptosis of MM cells via the Wnt/beta-catenin signaling pathway, suggesting that RRM2 may represent a novel therapeutic target for MM.
引用
收藏
页码:2159 / 2166
页数:8
相关论文
共 50 条
  • [1] RRM2 regulates osteogenesis of mouse embryo fibroblasts via the Wnt/β-catenin signaling pathway
    Cai, Haijun
    Guo, Hui
    Deng, Yixuan
    Jiang, Jinhai
    Liu, Siyuan
    He, Wenge
    Jian, Huagang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (04)
  • [2] Targeting the Wnt/Beta-Catenin Pathway in Multiple Myeloma
    Schmeel, Leonard Christopher
    Schmeel, Frederic Carsten
    Kim, Young
    Endo, Tomoyuki
    Lu, Desheng
    Schmidt-Wolf, Ingo G. H.
    ANTICANCER RESEARCH, 2013, 33 (11) : 4719 - 4726
  • [3] Targeting the Wnt/β-catenin signaling pathway in cancer
    Zhang, Ya
    Wang, Xin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [4] Targeting the Wnt/β-catenin signaling pathway in cancer
    Ya Zhang
    Xin Wang
    Journal of Hematology & Oncology, 13
  • [5] WNT/β-CATENIN SIGNALING PATHWAY: A TARGET FOR NOVEL THERAPEUTIC APPROACHES IN MULTIPLE MYELOMA
    Gast, S-M
    Kim, Y.
    Schmidt-Wolf, I. G. H.
    DRUGS OF THE FUTURE, 2013, 38 (11) : 757 - 763
  • [6] The role of Wnt/β-catenin signaling pathway in the pathogenesis and treatment of multiple myeloma (review)
    Yuan, Yuxia
    Guo, Mengjie
    Gu, Chunyan
    Yang, Ye
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 9932 - 9949
  • [7] Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway
    Liu, Ye-Mao
    Wu, An-Ding
    Chen, Yun
    Ma, Teng-Fei
    Dong, Bi-Zhen
    She, Zhi-Gang
    Yi, Mao-Lin
    Mao, Wei-Ming
    MEDICAL ONCOLOGY, 2023, 41 (01)
  • [8] Gastrodin inhibits prostate cancer proliferation by targeting canonical Wnt/β-catenin signaling pathway
    Ye-Mao Liu
    An-Ding Wu
    Yun Chen
    Teng-Fei Ma
    Bi-Zhen Dong
    Zhi-Gang She
    Mao-Lin Yi
    Wei-Ming Mao
    Medical Oncology, 41
  • [9] Targeting the Wnt/ β-Catenin Signaling Pathway in Multiple Myeloma: A Possible New Therapeutic Approach to Overcome Bortezomib-Resistance
    Tabayashi, Takayuki
    Takahashi, Yasuyuki
    Kimura, Yuta
    Tomikawa, Tatsuki
    Sagawa, Morihiko
    Nemoto, Tomoe
    Watanabe, Reiko
    Tokuhira, Michihide
    Mori, Shigehisa
    Kizaki, Masahiro
    BLOOD, 2014, 124 (21)
  • [10] The Wnt/beta-catenin signaling pathway - a promising approach in the treatment of the multiple myeloma?
    Kim, Y.
    Endo, T.
    Brossart, P.
    Schmidt-Wolf, I. G. H.
    ONKOLOGIE, 2010, 33 : 187 - 187